Autologous Hematopoietic Stem Cells May Treat Aggressive MS EffectivelyJanuary 9, 2019Multiple Sclerosis
Daclizumab beta may be superior to interferon beta on MS disability progressionJanuary 8, 2019Multiple Sclerosis
Does rituximab delay disability progression in patients with secondary progressive MS?January 7, 2019Multiple Sclerosis
Real-world data reveal long-lasting effects achieved with RRMS treatmentsDecember 13, 2018Multiple Sclerosis
Virus-Specific T-Cell Infusions May Resolve Progressive Multifocal LeukoencephalopathyDecember 11, 2018Multiple Sclerosis
Stroke, arterial dissection events reported with Lemtrada, FDA saysNovember 29, 2018Multiple Sclerosis
Particular lesions early after CIS predict long-term MS disabilityNovember 27, 2018Multiple Sclerosis
Panel Provides Recommendations for Managing Cognitive Changes in MSNovember 16, 2018Multiple Sclerosis
